hepatitis%20-%20viral
HEPATITIS - VIRAL
The majority of acute viral hepatitis infections are asymptomatic or they can cause an anicteric illness that may not be diagnosed as hepatitis.
Hepatitis A generally causes minor illness in childhood with >80% of infections being asymptomatic but more likely to produce clinical symptoms in adults. 
Hepatitis B, C, & D may also be asymptomatic.
Hepatitis A is predominantly transmitted through oral-fecal route.
Hepatitis B is transmitted through perinatal, percutaneous, or sexual routes or close person-to-person contact via open cuts and sores.
Hepatitis C infections are transmitted through perinatal, percutaneous, or sexual routes, blood transfusions, or organ transplants.
Hepatitis D's route of transmission is sexual or percutaneous, especially IV drug use.
Hepatitis E is transmitted primarily through contaminated drinking water and oral-fecal transmission.

Introduction

  • A self-limiting disease that is usually caused by viruses. As it progresses, it causes fibrosis (scarring), cirrhosis & cancer of the liver

Signs and Symptoms

  • The majority of acute viral hepatitis infections are asymptomatic or they can cause an anicteric illness that may not be diagnosed as hepatitis
  • Hepatitis A generally causes minor illness in childhood w/ >80% of infections being asymptomatic
    • Adults are more likely to produce clinical symptoms
  • Hepatitis B, C & D may also be asymptomatic
  • Symptomatic hepatitis B will depend on the mode & time of transmission
    • Vertical transmission from mother to child is almost always asymptomatic
    • Other routes of transmission are more likely to produce symptomatic disease (30% of cases transmitted by IV drug use are icteric)
Preicteric Phase
  • Nonspecific systemic symptoms (eg myalgia, nausea, vomiting, fatigue, malaise w/ discomfort in the right upper quadrant of the abdomen)
  • Altered sense of smell or taste, coryza, photophobia, headache, cough, diarrhea, dark urine & serum sickness-like syndrome
  • Hepatomegaly, splenomegaly & lymphadenopathy may be seen on physical exam
Icteric Phase
  • Jaundice, usually noted after onset of fever or upon lysis of fever
Fulminant Hepatitis
  • Development of symptoms of hepatic encephalopathy (eg confusion, drowsiness w/in 8 wk of symptoms or w/in 2 wk of onset of jaundice)
  • Hypoglycemia, prolonged prothrombin time (PT)

Pathogenesis

Routes of Transmission of Hepatitis

Hepatitis A: Oral-fecal

Hepatitis B: Perinatal, percutaneous, sexual, close person-to-person contact ie by open cuts & sores

Hepatitis C: Blood transfusions, organ transplants, percutaneous (esp IV drug use), sexual, perinatal

Hepatitis D: Sexual, percutaneous esp IV drug use

  • Found only in patients w/ hepatitis B since it requires the hepatitis B outer coat

Hepatitis E: Oral-fecal, blood transfusion in endemic areas

Incubation Period

Hepatitis A: 15-50 days

Hepatitis B: 40-180 days

Hepatitis C: 20-120 days

Hepatitis D: 30-180 days

Hepatitis E: 21-60 days

Other Characteristics of Hepatitis Viruses

  • Hepatitis B virus contains a DNA nucleic acid while A, C, & E viruses have an RNA nucleic acid
    • Hepatitis D has an incomplete RNA & needs the B virus to replicate
  • Hepatitis A & E viruses cause epidemics
  • Hepatitis B, C, & D viruses may predispose to chronic disease & hepatic malignancy
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Hepatology - Malaysia digital copy today!
DOWNLOAD
Editor's Recommendations
Most Read Articles
Pank Jit Sin, 17 Apr 2015
Diagnosis and treatment of NAFLD isn’t always precise, but new developments are helping to pave the way for better management of the disease, shares a panel of experts. 
Dr Joslyn Ngu, 12 Sep 2017
The MOH welcomes efforts by the Malaysian Liver Foundation (MLF), other professional bodies and pharmaceutical companies to work together to prevent hepatitis. 
Roshini Claire Anthony, 22 Apr 2016
A once-daily oral dose of the direct-acting antiviral agents (DAAs) ledipasvir/sofosbuvir (LDV/SOF) is safe and effective in treating adolescent genotype 1 (GT1) hepatitis C (HCV) patients, according to results of a study presented at the annual meeting of the European Association for the Study of the Liver (EASL) International Liver Congress™ (ILC) 2016 in Barcelona, Spain.
Tristan Manalac, 05 Sep 2017
Work stress appears to alter the metabolic profile and promote systemic inflammation, reveals a recent large-scale study on a French population. Moreover, work stress is also associated with poor liver function in males, suggesting elevated levels of alcohol consumption.